Clinical Trials Logo

Clinical Trial Summary

A method of ICG counterstaining localization under target artery occlusion without cutting,It's a new method of localization of small pulmonary nodules.


Clinical Trial Description

1. This technology can replace part of CT puncture-guided positioning, which not only saves CT positioning costs for patients, but also saves time and space resources in CT room; 2. The target artery occlusion technique does not cut off the blood vessels, and the operation is still a wedge resection. Compared with the standard segmentectomy/subsegmentectomy, the steps of cutting off the veins and bronchial tubes are reduced, the operation time is shortened, and the turnover rate is improved. 3. There is less damage to the lung tissue, and the lung function is well preserved. The patients can be discharged in an average of 3 days after the operation, which improves the bed turnover efficiency of the department. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06404164
Study type Interventional
Source Guangdong Provincial People's Hospital
Contact WenZhao Zhong
Phone +86-13609777314
Email 13609777314@163.com
Status Recruiting
Phase N/A
Start date January 30, 2022
Completion date December 30, 2027

See also
  Status Clinical Trial Phase
Recruiting NCT05686434 - Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR) Phase 2
Recruiting NCT04317534 - Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm Phase 2
Recruiting NCT04205552 - Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients Phase 2
Not yet recruiting NCT03446911 - Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery Phase 1/Phase 2
Not yet recruiting NCT06467383 - A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
Recruiting NCT04830826 - A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
Recruiting NCT03454685 - The Role of Microbiota on the Development of Lung Cancer
Enrolling by invitation NCT06028412 - Comparison of Segmentectomy and Lobectomy in Small (2 cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study N/A
Recruiting NCT03446547 - Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736) Phase 2